272 related articles for article (PubMed ID: 16172195)
21. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.
Yamazaki D; Kurisu S; Takenawa T
Oncogene; 2009 Apr; 28(13):1570-83. PubMed ID: 19234490
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells.
Li X; Liu L; Tupper JC; Bannerman DD; Winn RK; Sebti SM; Hamilton AD; Harlan JM
J Biol Chem; 2002 May; 277(18):15309-16. PubMed ID: 11839765
[TBL] [Abstract][Full Text] [Related]
23. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture.
Flint OP; Masters BA; Gregg RE; Durham SK
Toxicol Appl Pharmacol; 1997 Jul; 145(1):99-110. PubMed ID: 9221829
[TBL] [Abstract][Full Text] [Related]
24. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.
Tang D; Park HJ; Georgescu SP; Sebti SM; Hamilton AD; Galper JB
Life Sci; 2006 Sep; 79(15):1484-92. PubMed ID: 16740276
[TBL] [Abstract][Full Text] [Related]
25. Effects of cholesterol-lowering statins on the aqueous humor outflow pathway.
Song J; Deng PF; Stinnett SS; Epstein DL; Rao PV
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2424-32. PubMed ID: 15980231
[TBL] [Abstract][Full Text] [Related]
26. The role of geranylgeranylated proteins in human mesangial cell proliferation.
Khwaja A; Sharpe CC; Noor M; Hendry BM
Kidney Int; 2006 Oct; 70(7):1296-304. PubMed ID: 16929252
[TBL] [Abstract][Full Text] [Related]
27. 2-methoxyestradiol inhibits atorvastatin-induced rounding of human vascular smooth muscle cells.
Yin H; Gui Y; Zheng XL
J Cell Physiol; 2010 Mar; 222(3):556-64. PubMed ID: 19937728
[TBL] [Abstract][Full Text] [Related]
28. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
Hoque A; Chen H; Xu XC
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
[TBL] [Abstract][Full Text] [Related]
29. Protein geranylgeranylation is critical for the regulation of survival and proliferation of lymphoma tumor cells.
van de Donk NW; Schotte D; Kamphuis MM; van Marion AM; van Kessel B; Bloem AC; Lokhorst HM
Clin Cancer Res; 2003 Nov; 9(15):5735-48. PubMed ID: 14654559
[TBL] [Abstract][Full Text] [Related]
30. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells.
Camino-López S; Llorente-Cortés V; Sendra J; Badimon L
Cardiovasc Res; 2007 Jan; 73(1):208-16. PubMed ID: 17141748
[TBL] [Abstract][Full Text] [Related]
31. Lovastatin-induced RhoA modulation and its effect on senescence in prostate cancer cells.
Lee J; Lee I; Park C; Kang WK
Biochem Biophys Res Commun; 2006 Jan; 339(3):748-54. PubMed ID: 16316623
[TBL] [Abstract][Full Text] [Related]
32. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis.
Esemuede N; Lee T; Maier KG; Sumpio BE; Gahtan V
J Surg Res; 2011 Jun; 168(1):149-54. PubMed ID: 20338582
[TBL] [Abstract][Full Text] [Related]
33. Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin.
Wong WW; Tan MM; Xia Z; Dimitroulakos J; Minden MD; Penn LZ
Clin Cancer Res; 2001 Jul; 7(7):2067-75. PubMed ID: 11448925
[TBL] [Abstract][Full Text] [Related]
34. HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway.
Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
Biochem Biophys Res Commun; 2008 Sep; 374(2):309-14. PubMed ID: 18625202
[TBL] [Abstract][Full Text] [Related]
35. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
36. Mevastatin, an inhibitor of HMG-CoA reductase, induces apoptosis, differentiation and Rap1 expression in HL-60 cells.
Kanno T; Kobuchi H; Kajitani N; Utsumi T; Yano H; Horton AA; Yasuda T; Utsumi K
Physiol Chem Phys Med NMR; 2002; 34(1):1-15. PubMed ID: 12403272
[TBL] [Abstract][Full Text] [Related]
37. A cross-link between protein kinase A and Rho-family GTPases signaling mediates cell-cell adhesion and actin cytoskeleton organization in epithelial cancer cells.
Leve F; de Souza W; Morgado-Díaz JA
J Pharmacol Exp Ther; 2008 Dec; 327(3):777-88. PubMed ID: 18791066
[TBL] [Abstract][Full Text] [Related]
38. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
Song CY; Kim BC; Lee HS
Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125
[TBL] [Abstract][Full Text] [Related]
39. HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation.
Xu H; Zeng L; Peng H; Chen S; Jones J; Chew TL; Sadeghi MM; Kanwar YS; Danesh FR
Am J Physiol Renal Physiol; 2006 Nov; 291(5):F995-1004. PubMed ID: 16774905
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion.
Joshi B; Strugnell SS; Goetz JG; Kojic LD; Cox ME; Griffith OL; Chan SK; Jones SJ; Leung SP; Masoudi H; Leung S; Wiseman SM; Nabi IR
Cancer Res; 2008 Oct; 68(20):8210-20. PubMed ID: 18922892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
